Sarepta to present Phase 4 Duchenne drug data at neuromuscular meeting

September 24, 2026 8:30 AM

Sarepta Therapeutics (NASDAQ: SRPT) plans to present seven posters at the 27th Annual Neuromuscular Study Group Scientific Meeting, scheduled for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found